4.7 Article

Breath testing for SARS-CoV-2 infection

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

HMDB 5.0: the Human Metabolome Database for 2022

David S. Wishart et al.

Summary: The Human Metabolome Database (HMDB) has been providing comprehensive information about human metabolites since 2007, and has undergone significant improvements and upgrades in its latest update, HMDB 5.0. These improvements include an increase in the number of metabolite entries, enhancements to metabolite descriptions, new visualization tools, and more accurately predicted spectral data sets. These upgrades are aimed at improving the usability and potential applications of the HMDB in various fields, including human metabolomics, exposomics, lipidomics, nutritional science, biochemistry, and clinical chemistry.

NUCLEIC ACIDS RESEARCH (2022)

Article Medicine, General & Internal

Metabolomics of exhaled breath in critically ill COVID-19 patients: A pilot study

Stanislas Grassin-Delyle et al.

Summary: This study characterized the exhaled breath from mechanically ventilated adults with COVID-19 using real-time proton transfer reaction time-of-flight mass spectrometry. The analysis was able to differentiate between COVID-19 and non-COVID-19 ARDS with high accuracy. Characteristic volatile compounds were identified in the exhaled breath of COVID-19 patients, showing potential for early diagnosis.

EBIOMEDICINE (2021)

Article Chemistry, Medicinal

Reproducible Breath Metabolite Changes in Children with SARS-CoV-2 Infection

Amalia Z. Berna et al.

Summary: Analysis of breath samples revealed six volatile organic compounds significantly increased in the breath of children infected with SARS-CoV-2, with high accuracy for distinguishing infection. These biomarkers support the ongoing development of novel breath-based diagnostics for pediatric COVID-19.

ACS INFECTIOUS DISEASES (2021)

Article Respiratory System

Diagnosis of COVID-19 by exhaled breath analysis using gas chromatography-mass spectrometry

Wadah Ibrahim et al.

Summary: The study aimed to evaluate the role of exhaled breath volatile biomarkers in identifying patients with suspected or confirmed COVID-19 infection. The results showed that GC-MS-detected exhaled breath biomarkers were able to identify PCR-positive COVID-19 patients. External replication of these compounds is needed to validate the results.

ERJ OPEN RESEARCH (2021)

Article Biochemistry & Molecular Biology

Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery

Yuming Li et al.

Summary: This study identified potential therapeutic targets and biomarkers for predicting disease severity in COVID-19 patients through multi-platform omics analysis, with validation of predictive power.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Article Multidisciplinary Sciences

Plasma metabolomic and lipidomic alterations associated with COVID-19

Di Wu et al.

NATIONAL SCIENCE REVIEW (2020)

Article Gastroenterology & Hepatology

Volatile Organic Compounds in Exhaled Air as Novel Marker for Disease Activity in Crohn's Disease: A Metabolomic Approach

Alexander G. L. Bodelier et al.

INFLAMMATORY BOWEL DISEASES (2015)

Article Respiratory System

Breath Analysis in Real Time by Mass Spectrometry in Chronic Obstructive Pulmonary Disease

Pablo Martinez-Lozano Sinues et al.

RESPIRATION (2014)

Article Biochemical Research Methods

Allergic asthma exhaled breath metabolome: A challenge for comprehensive two-dimensional gas chromatography

M. Caldeira et al.

JOURNAL OF CHROMATOGRAPHY A (2012)

Article Respiratory System

Non-invasive phenotyping using exhaled volatile organic compounds in asthma

Baharudin Ibrahim et al.

THORAX (2011)

Article Critical Care Medicine

Aldehydes in exhaled breath condensate of patients with chronic obstructive pulmonary disease

M Corradi et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)